ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancer.
作者:
主题词
动物(Animals);人类(Humans);小鼠(Mice);抗肿瘤药(Antineoplastic Agents);细胞系, 肿瘤(Cell Line, Tumor);抗药性, 肿瘤(Drug Resistance, Neoplasm);上皮-间质转化(Epithelial-Mesenchymal Transition);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);信号传导(Signal Transduction);膀胱肿瘤(Urinary Bladder Neoplasms)
DOI
10.1007/s12094-022-03044-x
PMID
36512304
发布时间
2023-04-26
- 浏览0

Clinical & translational oncology
1425-1435页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文